Topelia Australia

Topelia Australia is a biotechnology company dedicated to the research and commercialization of novel ATT therapies. The establishment of Topelia Australia is based on extensive experience in pioneering ATT therapies in the field of peptic ulcer disease, which has saved more than 18,000 lives in Australia alone and saved the Australian government over 10 billion U.S. dollars in related healthcare costs. Topelia Australia holds the patent rights for this novel ATT therapy.